Denise Casey

455 total citations
15 papers, 243 citations indexed

About

Denise Casey is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Denise Casey has authored 15 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Oncology. Recurrent topics in Denise Casey's work include Childhood Cancer Survivors' Quality of Life (5 papers), Ethics and Legal Issues in Pediatric Healthcare (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Denise Casey is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (5 papers), Ethics and Legal Issues in Pediatric Healthcare (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Denise Casey collaborates with scholars based in United States, Netherlands and Belgium. Denise Casey's co-authors include Richard Pazdur, Patricia Keegan, Huanyu Chen, Whitney S. Helms, Stacy S. Shord, Hong Zhao, Suzanne Demko, Kun He, Gregory H. Reaman and Amy Barone and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and PEDIATRICS.

In The Last Decade

Denise Casey

15 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Denise Casey United States	8	92	54	52	43	37	15	243
Marc Earl United States	11	34 0.4×	137 2.5×	73 1.4×	92 2.1×	34 0.9×	24	288
Asmâa Quessar Morocco	9	49 0.5×	65 1.2×	34 0.7×	39 0.9×	19 0.5×	50	244
Deepam Pushpam India	10	33 0.4×	91 1.7×	52 1.0×	64 1.5×	14 0.4×	74	272
Leigh Boehmer United States	9	47 0.5×	96 1.8×	40 0.8×	53 1.2×	17 0.5×	42	253
Setareh Akhavan Iran	10	57 0.6×	46 0.9×	35 0.7×	22 0.5×	56 1.5×	57	291
A. D. Hibberd Australia	13	35 0.4×	99 1.8×	18 0.3×	104 2.4×	32 0.9×	39	405
Katie S. Gatwood United States	8	50 0.5×	111 2.1×	32 0.6×	23 0.5×	13 0.4×	33	255
Srirama Josyula United States	10	144 1.6×	90 1.7×	95 1.8×	17 0.4×	42 1.1×	12	447
Tomasz Ociepa Poland	8	25 0.3×	32 0.6×	40 0.8×	49 1.1×	10 0.3×	28	136
Mariana Fernandes United Kingdom	12	66 0.7×	26 0.5×	18 0.3×	8 0.2×	33 0.9×	59	702

Countries citing papers authored by Denise Casey

Since Specialization

Citations

This map shows the geographic impact of Denise Casey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Casey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Casey more than expected).

Fields of papers citing papers by Denise Casey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Casey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Casey. The network helps show where Denise Casey may publish in the future.

Co-authorship network of co-authors of Denise Casey

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Casey. A scholar is included among the top collaborators of Denise Casey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Casey. Denise Casey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Luke, Jason J., Manish Sharma, Sreenivasa R Chandana, et al.. (2023). Lorigerlimab, a bispecific PD-1×CTLA-4 DART molecule in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A phase 1 expansion (exp) cohort.. Journal of Clinical Oncology. 41(6_suppl). 155–155. 7 indexed citations

Abdelbaki, Mohamed S, Timothy P. Cripe, Richard Curry, et al.. (2022). An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 8(12). e12450–e12450. 2 indexed citations

Miller, David M., Sophia Z. Shalhout, Denise Casey, et al.. (2022). Impact of an evolving regulatory landscape on skin cancer drug development in the U.S.. Dermatology Online Journal. 28(2). 10 indexed citations

Kaminker, Patrick, et al.. (2022). 757 A phase 1/1b dose escalation and cohort expansion study of MGC018 in combination with lorigerlimab in patients with advanced solid tumors (AST). Regular and Young Investigator Award Abstracts. A789–A789. 4 indexed citations

Reaman, Gregory H., Dominik Karres, Franca Ligas, et al.. (2020). Accelerating the Global Development of Pediatric Cancer Drugs: A Call to Coordinate the Submissions of Pediatric Investigation Plans and Pediatric Study Plans to the European Medicines Agency and US Food and Drug Administration. Journal of Clinical Oncology. 38(36). 4227–4230. 14 indexed citations

Barone, Amy, Denise Casey, Amy E. McKee, & Gregory H. Reaman. (2019). Cancer drugs approved for use in children: Impact of legislative initiatives and future opportunities. Pediatric Blood & Cancer. 66(8). e27809–e27809. 25 indexed citations

Cannon, Ashley, Kurt Jarnagin, Bruce R. Korf, et al.. (2018). Clinical trial design for cutaneous neurofibromas. Neurology. 91(2_Supplement_1). S31–S37. 7 indexed citations

Cheng, Connie, et al.. (2018). Wound healing complications with lenvatinib identified in a pharmacovigilance database. Journal of Oncology Pharmacy Practice. 25(8). 1817–1822. 11 indexed citations

Leong, Rupert W., Hong Zhao, Amy Barone, et al.. (2017). Pediatric Development of Molecularly Targeted Oncology Drugs. Clinical Pharmacology & Therapeutics. 104(2). 384–389. 4 indexed citations

10.

Casey, Denise, Suzanne Demko, Stacy S. Shord, et al.. (2017). FDA Approval Summary: Sonidegib for Locally Advanced Basal Cell Carcinoma. Clinical Cancer Research. 23(10). 2377–2381. 98 indexed citations

11.

Casey, Denise, et al.. (2016). Feasibility of Early Palliative Care Consultation for Children With High-Risk Malignancies. Pediatric Blood & Cancer. 63(8). 1419–1422. 19 indexed citations

12.

Dozier, Ann, et al.. (2014). Early palliative care involvement for children with cancer.. Journal of Clinical Oncology. 32(31_suppl). 26–26. 1 indexed citations

13.

Casey, Denise, et al.. (2013). Health Care Failure Mode and Effect Analysis to Reduce NICU Line–Associated Bloodstream Infections. PEDIATRICS. 131(6). e1961–e1969. 32 indexed citations

14.

Hamilton, Susan, et al.. (2013). A Pediatric Critical Care Practice Group: Use of Expertise and Evidence-Based Practice in Identifying and Establishing “Best” Practice. Critical Care Nurse. 33(2). 85–87. 4 indexed citations

15.

Beinecke, Richard H., et al.. (1999). The Massachusetts Behavioral Health Program Year 5: Transition to a New Managed Care Organization. Administration and Policy in Mental Health and Mental Health Services Research. 26(5). 313–327. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact